Concepts (243)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shock, Septic | 5 | 2018 | 1313 | 1.36 | Why? |
| Anemia, Sickle Cell | 6 | 2020 | 546 | 1.28 | Why? |
| Ventilator Weaning | 2 | 2019 | 536 | 1.02 | Why? |
| Positive-Pressure Respiration | 3 | 2020 | 1160 | 1.01 | Why? |
| Pulmonary Artery | 3 | 2018 | 803 | 0.93 | Why? |
| Acute Chest Syndrome | 2 | 2020 | 140 | 0.82 | Why? |
| Thrombopoiesis | 1 | 2018 | 39 | 0.74 | Why? |
| Pneumonia, Ventilator-Associated | 3 | 2021 | 861 | 0.73 | Why? |
| Hypovolemia | 1 | 2018 | 65 | 0.71 | Why? |
| Tongue Diseases | 1 | 2017 | 41 | 0.66 | Why? |
| Diaphragm | 2 | 2017 | 232 | 0.64 | Why? |
| Telomere Shortening | 1 | 2017 | 66 | 0.64 | Why? |
| Tongue | 1 | 2017 | 132 | 0.62 | Why? |
| Blood Flow Velocity | 1 | 2017 | 193 | 0.61 | Why? |
| Cardiac Tamponade | 1 | 2018 | 165 | 0.58 | Why? |
| Muscle Strength | 1 | 2017 | 317 | 0.57 | Why? |
| Pulmonary Circulation | 1 | 2017 | 207 | 0.57 | Why? |
| Antiphospholipid Syndrome | 1 | 2021 | 533 | 0.56 | Why? |
| Adrenal Insufficiency | 1 | 2017 | 190 | 0.55 | Why? |
| Vagina | 1 | 2017 | 327 | 0.54 | Why? |
| Muscle Weakness | 1 | 2017 | 406 | 0.53 | Why? |
| Pulmonary Heart Disease | 1 | 2013 | 47 | 0.50 | Why? |
| Myocardial Ischemia | 1 | 2019 | 781 | 0.48 | Why? |
| Acute Lung Injury | 2 | 2017 | 904 | 0.46 | Why? |
| Shock | 1 | 2018 | 1868 | 0.43 | Why? |
| Shock, Cardiogenic | 1 | 2017 | 700 | 0.42 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.41 | Why? |
| Purpura Fulminans | 2 | 2019 | 22 | 0.39 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2018 | 994 | 0.38 | Why? |
| Respiratory Tract Diseases | 1 | 2017 | 1061 | 0.38 | Why? |
| Anaphylaxis | 1 | 2018 | 940 | 0.37 | Why? |
| Ventricular Dysfunction, Left | 1 | 2017 | 993 | 0.36 | Why? |
| Respiration, Artificial | 8 | 2021 | 22116 | 0.36 | Why? |
| Cardiomyopathies | 1 | 2017 | 997 | 0.35 | Why? |
| Staphylococcal Infections | 1 | 2017 | 1099 | 0.33 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.33 | Why? |
| Inflammation Mediators | 1 | 2018 | 2654 | 0.32 | Why? |
| Respiratory Mechanics | 2 | 2020 | 585 | 0.31 | Why? |
| Work of Breathing | 2 | 2017 | 86 | 0.28 | Why? |
| Thrombocytopenia | 1 | 2018 | 2093 | 0.28 | Why? |
| Platelet Count | 2 | 2018 | 1381 | 0.22 | Why? |
| Hemoglobins | 2 | 2017 | 958 | 0.22 | Why? |
| Mice, Inbred C57BL | 5 | 2018 | 5542 | 0.22 | Why? |
| Aging | 1 | 2017 | 3581 | 0.21 | Why? |
| Heart Diseases | 1 | 2017 | 3503 | 0.20 | Why? |
| Intensive Care Units | 8 | 2021 | 29594 | 0.20 | Why? |
| Pancreatic Elastase | 1 | 2018 | 41 | 0.19 | Why? |
| Interleukin-6 | 1 | 2017 | 7522 | 0.19 | Why? |
| Embolism, Paradoxical | 1 | 2018 | 22 | 0.18 | Why? |
| Electric Impedance | 1 | 2020 | 283 | 0.18 | Why? |
| Nitric Oxide Donors | 1 | 2018 | 53 | 0.18 | Why? |
| Male | 32 | 2021 | 367725 | 0.18 | Why? |
| Anti-Inflammatory Agents | 1 | 2017 | 6153 | 0.17 | Why? |
| Tomography, X-Ray Computed | 4 | 2020 | 25144 | 0.17 | Why? |
| Middle Aged | 24 | 2021 | 270681 | 0.17 | Why? |
| Intracranial Embolism | 1 | 2018 | 73 | 0.17 | Why? |
| Hypokinesia | 1 | 2017 | 52 | 0.17 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.17 | Why? |
| Gene Dosage | 1 | 2017 | 101 | 0.17 | Why? |
| Bronchoalveolar Lavage | 1 | 2021 | 603 | 0.17 | Why? |
| Bronchoalveolar Lavage Fluid | 4 | 2021 | 2309 | 0.17 | Why? |
| Cardiac Output | 1 | 2018 | 183 | 0.16 | Why? |
| Cellular Senescence | 2 | 2017 | 326 | 0.16 | Why? |
| Menstruation | 1 | 2017 | 81 | 0.16 | Why? |
| Blood Viscosity | 1 | 2017 | 71 | 0.16 | Why? |
| Female | 27 | 2021 | 380317 | 0.16 | Why? |
| Streptococcus pyogenes | 1 | 2017 | 118 | 0.16 | Why? |
| Organ Size | 1 | 2017 | 384 | 0.16 | Why? |
| Vascular Resistance | 1 | 2017 | 148 | 0.16 | Why? |
| beta-Lactams | 1 | 2018 | 210 | 0.16 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.16 | Why? |
| Prospective Studies | 9 | 2021 | 43301 | 0.16 | Why? |
| Delphi Technique | 1 | 2021 | 1257 | 0.16 | Why? |
| Th17 Cells | 1 | 2021 | 657 | 0.15 | Why? |
| Legionnaires' Disease | 1 | 2017 | 108 | 0.15 | Why? |
| France | 6 | 2020 | 12074 | 0.15 | Why? |
| Fluoroquinolones | 1 | 2017 | 235 | 0.15 | Why? |
| Erythrocyte Indices | 1 | 2017 | 207 | 0.15 | Why? |
| Foramen Ovale, Patent | 1 | 2018 | 153 | 0.15 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.15 | Why? |
| Transfusion Reaction | 1 | 2017 | 245 | 0.15 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.14 | Why? |
| Hemolysis | 1 | 2017 | 283 | 0.14 | Why? |
| Metagenomics | 1 | 2021 | 823 | 0.14 | Why? |
| Th1 Cells | 1 | 2021 | 1228 | 0.14 | Why? |
| Macrophages, Alveolar | 1 | 2018 | 668 | 0.14 | Why? |
| Chemokines | 1 | 2020 | 1095 | 0.14 | Why? |
| Humans | 38 | 2021 | 930598 | 0.13 | Why? |
| Plasma Exchange | 1 | 2021 | 763 | 0.13 | Why? |
| Pericardial Effusion | 1 | 2018 | 312 | 0.13 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.13 | Why? |
| Streptococcal Infections | 1 | 2017 | 255 | 0.13 | Why? |
| Statistics, Nonparametric | 1 | 2017 | 1008 | 0.13 | Why? |
| Invasive Pulmonary Aspergillosis | 1 | 2020 | 634 | 0.13 | Why? |
| Erythrocyte Transfusion | 1 | 2017 | 386 | 0.13 | Why? |
| Airway Extubation | 1 | 2018 | 403 | 0.13 | Why? |
| Pneumonia, Bacterial | 2 | 2017 | 843 | 0.12 | Why? |
| Pulmonary Edema | 1 | 2017 | 430 | 0.12 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.12 | Why? |
| Arterial Occlusive Diseases | 1 | 2017 | 363 | 0.12 | Why? |
| Natriuretic Peptide, Brain | 1 | 2019 | 1215 | 0.12 | Why? |
| Body Weight | 1 | 2018 | 1074 | 0.11 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.11 | Why? |
| Adult | 16 | 2021 | 244371 | 0.11 | Why? |
| Syndrome | 1 | 2017 | 1310 | 0.11 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 5002 | 0.11 | Why? |
| Erythrocytes | 1 | 2017 | 617 | 0.11 | Why? |
| Nitric Oxide | 1 | 2018 | 769 | 0.11 | Why? |
| Carbon Dioxide | 1 | 2017 | 917 | 0.10 | Why? |
| Respiratory Function Tests | 1 | 2017 | 1755 | 0.10 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.10 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.10 | Why? |
| Aged | 16 | 2021 | 215776 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Autoantibodies | 1 | 2021 | 2094 | 0.10 | Why? |
| Echocardiography, Transesophageal | 1 | 2013 | 447 | 0.10 | Why? |
| Heart Ventricles | 1 | 2018 | 1139 | 0.10 | Why? |
| Peptide Fragments | 1 | 2019 | 2075 | 0.09 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.09 | Why? |
| Immunoglobulin A | 1 | 2020 | 3567 | 0.09 | Why? |
| Biomarkers | 3 | 2019 | 23361 | 0.09 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2018 | 1047 | 0.09 | Why? |
| Stroke Volume | 1 | 2018 | 2153 | 0.09 | Why? |
| Transcriptome | 1 | 2021 | 3466 | 0.09 | Why? |
| Interferon Type I | 1 | 2021 | 2789 | 0.09 | Why? |
| Inflammation | 3 | 2018 | 13255 | 0.08 | Why? |
| Anti-Bacterial Agents | 3 | 2018 | 10083 | 0.08 | Why? |
| Case-Control Studies | 3 | 2020 | 17671 | 0.08 | Why? |
| Survivors | 1 | 2019 | 2619 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Echocardiography | 2 | 2018 | 3661 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.07 | Why? |
| Disease Models, Animal | 3 | 2018 | 10998 | 0.07 | Why? |
| Predictive Value of Tests | 2 | 2017 | 9537 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2017 | 2328 | 0.07 | Why? |
| Proportional Hazards Models | 1 | 2017 | 6543 | 0.07 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.07 | Why? |
| Critical Care | 2 | 2018 | 14081 | 0.07 | Why? |
| Disease Susceptibility | 1 | 2017 | 4002 | 0.07 | Why? |
| Postpartum Period | 1 | 2020 | 936 | 0.06 | Why? |
| Mice | 3 | 2018 | 21357 | 0.06 | Why? |
| Ultrasonography | 2 | 2017 | 4409 | 0.06 | Why? |
| Sepsis | 2 | 2018 | 3517 | 0.06 | Why? |
| Pneumonia | 3 | 2018 | 5652 | 0.06 | Why? |
| Oxygen | 1 | 2017 | 3715 | 0.06 | Why? |
| Risk Assessment | 3 | 2017 | 25439 | 0.06 | Why? |
| Prevalence | 2 | 2017 | 25773 | 0.06 | Why? |
| Viral Load | 2 | 2020 | 15850 | 0.06 | Why? |
| Comorbidity | 2 | 2017 | 34796 | 0.06 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.06 | Why? |
| Animals | 5 | 2018 | 78931 | 0.06 | Why? |
| Patient Selection | 1 | 2017 | 4560 | 0.06 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Receptors, Interleukin-8B | 1 | 2021 | 36 | 0.06 | Why? |
| Young Adult | 5 | 2019 | 93724 | 0.05 | Why? |
| Brain | 1 | 2018 | 5133 | 0.05 | Why? |
| Hospital Mortality | 4 | 2021 | 22087 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.05 | Why? |
| Respiratory Insufficiency | 1 | 2021 | 7301 | 0.05 | Why? |
| Cefotaxime | 1 | 2018 | 31 | 0.05 | Why? |
| Mice, Obese | 1 | 2018 | 29 | 0.05 | Why? |
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2018 | 24 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Treatment Outcome | 3 | 2020 | 51732 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2018 | 4775 | 0.05 | Why? |
| Cohort Studies | 2 | 2019 | 36005 | 0.04 | Why? |
| Cyclic GMP | 1 | 2018 | 50 | 0.04 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.04 | Why? |
| Amoxicillin | 1 | 2018 | 98 | 0.04 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.04 | Why? |
| Nitric Oxide Synthase Type III | 1 | 2018 | 87 | 0.04 | Why? |
| Quality of Life | 1 | 2019 | 9820 | 0.04 | Why? |
| Tomography, Emission-Computed | 1 | 2017 | 27 | 0.04 | Why? |
| Muscle, Smooth, Vascular | 1 | 2018 | 86 | 0.04 | Why? |
| Heme Oxygenase-1 | 1 | 2018 | 90 | 0.04 | Why? |
| Phosphodiesterase 5 Inhibitors | 1 | 2018 | 104 | 0.04 | Why? |
| Ventilators, Mechanical | 2 | 2021 | 2193 | 0.04 | Why? |
| Diet, High-Fat | 1 | 2018 | 161 | 0.04 | Why? |
| Obesity | 1 | 2018 | 7388 | 0.04 | Why? |
| Myocytes, Smooth Muscle | 1 | 2018 | 127 | 0.04 | Why? |
| Neisseria meningitidis | 1 | 2018 | 229 | 0.04 | Why? |
| Blood Preservation | 1 | 2017 | 191 | 0.04 | Why? |
| Monocytes | 2 | 2018 | 2978 | 0.04 | Why? |
| Amputation | 1 | 2018 | 331 | 0.04 | Why? |
| Age Factors | 1 | 2017 | 21039 | 0.04 | Why? |
| Meningococcal Infections | 1 | 2018 | 216 | 0.04 | Why? |
| Neurologic Examination | 1 | 2018 | 428 | 0.04 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.04 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.04 | Why? |
| Drug Therapy, Combination | 2 | 2020 | 7268 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Paris | 1 | 2018 | 1287 | 0.03 | Why? |
| Europe | 2 | 2021 | 12702 | 0.03 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.03 | Why? |
| Bronchoscopy | 1 | 2021 | 991 | 0.03 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.03 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.03 | Why? |
| Neutrophils | 2 | 2018 | 5476 | 0.03 | Why? |
| Blood Banks | 1 | 2017 | 535 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2018 | 2739 | 0.03 | Why? |
| Cell Proliferation | 1 | 2018 | 1973 | 0.03 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.03 | Why? |
| Cerebrovascular Disorders | 1 | 2018 | 1040 | 0.03 | Why? |
| Swine | 1 | 2018 | 3352 | 0.02 | Why? |
| Prognosis | 1 | 2013 | 32490 | 0.02 | Why? |
| Airway Management | 1 | 2018 | 1298 | 0.02 | Why? |
| Coronary Angiography | 1 | 2018 | 2275 | 0.02 | Why? |
| Fatal Outcome | 1 | 2018 | 3438 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.02 | Why? |
| Blood Transfusion | 1 | 2017 | 1399 | 0.02 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.02 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Cells, Cultured | 1 | 2018 | 5835 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| Bacterial Infections | 1 | 2018 | 2229 | 0.02 | Why? |
| Time Factors | 2 | 2018 | 31397 | 0.02 | Why? |
| Electrocardiography | 1 | 2018 | 3957 | 0.02 | Why? |
| Time-to-Treatment | 1 | 2020 | 5883 | 0.02 | Why? |
| Hypoxia | 1 | 2018 | 3626 | 0.02 | Why? |
| Feasibility Studies | 1 | 2012 | 3467 | 0.01 | Why? |
| Monitoring, Physiologic | 1 | 2012 | 1956 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Lung | 2 | 2018 | 31049 | 0.01 | Why? |
| Hospitals, University | 1 | 2012 | 4173 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Registries | 1 | 2018 | 12327 | 0.01 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.01 | Why? |
| Hospitalization | 1 | 2017 | 54280 | 0.00 | Why? |
Mekontso-Dessap's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(243)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(221)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_